Published online May 26, 2023. doi: 10.12998/wjcc.v11.i15.3491
Peer-review started: January 25, 2023
First decision: March 14, 2023
Revised: March 25, 2023
Accepted: April 13, 2023
Article in press: April 13, 2023
Published online: May 26, 2023
Acute lower extremity arterial embolism is a clinical emergency, if not treated in time, easy to lead to limb ischemia necrosis, eventually amputation, serious damage to the physical and mental health of the patient.
In the past, the effect of conventional drug thrombolytic therapy was slow and limited, and the optimal treatment time was easily delayed. Timely treatment of acute limb ischemia is essential to minimize the duration of ischemia.
To investigate the effect of angiojet in acute lower extremity arterial embolization.
Through the collection and analysis of patients with acute lower limb artery embolization admitted to our hospital from May 2018 to May 2020, the postoperative complication rate, recurrence rate and recovery of the two groups of patients who underwent vascular injection thrombolysis and femoral artery incision thrombolysis were compared.
There were no significant differences in postoperative recurrence, anklebrachial index and the incidence of postoperative complications between the two groups; there were statistically significant differences in postoperative pain score and postoperative rehabilitation between the two groups.
It is safe and effective that the application of angiojet in the treatment of acute lower extremity arterial thromboembolism.
Prospective studies should be conducted to expand the sample size and extend follow-up time to assess related risk factors and summarize more clinical experience, so as to accumulate experience, improve techniques and better grasp indications.